10.1016/0165-1218(88)90124-3
10.1016/0165-7992(93)90065-4
10.1016/S0140-6736(98)06099-1
10.1016/0304-3835(86)90182-5
10.1016/j.mrgentox.2004.11.007
Besaratinia A., 2003, JNCI, 95, 889, 10.1093/jnci/95.12.889
Besaratinia A., 2005, Mutat. Res, 580, 31, 10.1016/j.mrgentox.2004.10.011
10.1016/S0378-4274(02)00495-2
Bull R. J., 1984, Cancer Res, 44, 107
10.1016/0304-3835(84)90138-1
Burek J. D., 1980, J. Environ. Pathol. Toxicol, 4, 157
10.1016/0165-7992(88)90117-0
Cihak R., 1990, Mutat. Res, 234, 125, 10.1016/0165-1161(90)90003-7
Cohen S. M., 1999, IARC Sci. Publ, 175
10.1016/0165-7992(92)90023-B
10.1097/00043764-198907000-00013
Costa L. G., 1992, Neurotoxicology, 13, 219
1999, Consideration of the potency classification of acrylamide based on the incidence of tunica vaginalis mesotheliomas (TVMs) in F344 rats
2000, The biological role of acrylamide-induced thyroid follicular cell tumors in the aging F344 rat to human health outcomes
Dearfield K. L., 1988, Mutat. Res, 195, 45, 10.1016/0165-1110(88)90015-2
10.1016/0027-5107(95)00037-J
10.1002/(SICI)1520-6866(2000)20:3<133::AID-TCM4>3.0.CO;2-B
10.1016/j.mrgentox.2004.10.013
10.1016/j.taap.2004.07.001
10.1016/j.fct.2004.11.004
Ehling U. H., 1983, Mutat. Res, 123, 281, 10.1016/0165-1110(83)90026-X
Favor J., 2005, Mutat. Res, 580, 21, 10.1016/j.mrgentox.2004.09.010
10.1016/0272-0590(90)90254-H
2003, Joint Foods Standards Programme Codex Committee on Food Additives and Contaminants. Discussion paper on acrylamide
Frankos V., 1985, Critical review of acrylamide's carcinogenic activity in Fischer 344 rats: Design of a new cancer bioassay in rats
10.1016/S0890-6238(99)00043-X
10.1016/S0165-1218(96)90106-8
10.1016/0165-1218(85)90075-8
1994, IARC Monog. Eval. Carcinogen. Risks Hum, 60, 389
JECFA. Joint FAO/WHO Expert Committee on Food Additives. 64th Meeting. February, Rome, Italy. WHO Technical Report Series, in press
10.1016/j.mrgentox.2004.11.011
10.1016/0041-008X(86)90109-2
Klassen, C. D., ed. 2001.Casarett and Doull's toxicology, The basic science of poisons,, 6th, 820New York: McGraw-Hill.
10.1016/S0278-6915(03)00187-X
10.1016/j.toxlet.2004.07.008
10.1016/0027-5107(94)90100-7
10.1016/j.neuro.2004.01.004
LoPachin R. M., 1994, Neurotoxicology, 15, 247
10.1016/S0161-813X(01)00074-2
10.1016/S0041-008X(02)00072-8
Maniere I., 2005, Mutat. Res, 580, 119, 10.1016/j.mrgentox.2004.10.012
10.1016/j.fct.2004.10.003
10.1095/biolreprod60.4.1047
10.1146/annurev.pa.25.040185.003235
Mitchell J. R., 1973, J. Pharmacol. Exp. Ther, 187, 185
Nesterova E. V., 1999, Mutat. Res, 440, 171, 10.1016/S1383-5718(99)00024-8
Paulsson B., 2003, Mutat. Res, 535, 15, 10.1016/S1383-5718(02)00281-4
10.1016/j.mrgentox.2004.11.009
10.1016/j.mrgentox.2004.09.008
10.1016/j.fct.2003.10.017
10.1016/0027-5107(94)90101-5
Sega G. A., 1991, Prog. Clin. Biol. Res, 372, 521
Sega G. A., 1989, Mutat. Res, 216, 221, 10.1016/0165-1161(89)90008-3
10.1016/0165-7992(86)90008-4
Shiraishi Y., 1978, Mutat. Res, 57, 313, 10.1016/0027-5107(78)90216-6
10.1002/(SICI)1097-4547(19961001)46:1<7::AID-JNR2>3.0.CO;2-P
10.1016/0165-7992(86)90023-0
Sobel W., 1986, Br. J. Ind. Med, 43, 785
Spencer P. S., 1974, Can. J. Neurol. Sci, 1, 143, 10.1017/S0317167100019739
Spencer P. S., 1974, Can. J. Neurol. Sci, 1, 152, 10.1017/S0317167100119201
10.1016/0300-483X(89)90174-1
10.1016/S0278-6915(03)00188-1
Tilson H. A., 1981, Neurobehav. Toxicol. Teratol, 3, 445
Turek F. W., 1979, JNCI, 63, 969
10.1016/j.canlet.2003.10.017
10.1016/S0890-6238(02)00078-3
10.1016/S0890-6238(00)00066-6
10.1016/S0890-6238(00)00097-6
10.1016/0892-0362(94)00071-K
1985, Acrylamide. Environmental Health Criteria 40
1996, Guidelines for drinking water quality,, 2, 2
10.1080/15287398609530840
